Pieris Pharmaceuticals, Inc. announced that Darlene Deptula-Hicks has submitted her resignation, effective February 7, 2017, to pursue other interests. While the company conducts an executive search for a permanent successor, Lance Thibault of Danforth Advisors, is assuming the role of Acting Chief Financial Officer. Ms. Darlene Deptula-Hicks joined Pieris Pharmaceuticals as Senior Vice President and Chief Financial Officer in September 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | -3.43% | -2.72% | -31.32% |
1st Jan change | Capi. | |
---|---|---|
-31.32% | 13.2M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+4.43% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-15.31% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Announces Management Changes